Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001631 |
---|---|
Receipt number | R000001963 |
Scientific Title | Phase II study of a combination of CPT-11 and S-1 and bevacizumab in patients with metastatic colon cancer. |
Date of disclosure of the study information | 2009/01/14 |
Last modified on | 2019/02/03 21:26:04 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/01/14 00:11:25 | ||
2 | Update | 2012/10/24 10:28:58 | Post marketing survey by drug manufacture etc., specified by Japanese law. Email1 |
|
3 | Update | 2012/10/24 10:29:35 | Recruitment status Publication of results |
|
4 | Update | 2019/02/03 21:26:04 | Recruitment status Publication of results |